Clinical trial

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

NCT03802162

Study summary

ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention CKD-355A (D797/Memantine HCl 20mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CKD-355B (D797/Memantine HCl 20mg) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention D797 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention D324 (Memantine HCl 10mg) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-15

PhasePHASE1

Conditions

Alzheimer's Disease (AD)unresolved

Interventions

CKD-355A (D797/Memantine HCl 20mg)DRUG

CKD-355B (D797/Memantine HCl 20mg)DRUG

D797DRUG

D324 (Memantine HCl 10mg)DRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03802162 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.